TORRENT PHARMACEUTICALS L vs YATHARTH HOSP & TRA C S L
A side-by-side comparison of TORRENT PHARMACEUTICALS L (TORNTPHARM) and YATHARTH HOSP & TRA C S L (YATHARTH) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, TORRENT PHARMACEUTICALS L leads TORNTPHARM vs YATHARTH on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
- − ["Stock is trading at 19.8 times its book value", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
- + ["Company is expected to give good quarter", "Company has delivered good profit growth of 57.4% CAGR over last 5 years", "Company's working capital requirements have reduced from 102 days to 80.1 days"]
- − ["Though the company is reporting repeated profits, it is not paying out dividend", "Company has a low return on equity of 12.1% over last 3 years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.